Dempsey Details Shire’s Xiidra Strategy

Robert Dempsey, head of the ophthalmics franchise for Shire, lays out how Shire rolled out the commercial launch of Xiidra, the company’s new potential blockbuster treatment for dry eye. He also talked about the firm’s personnel additions and Xiidra’s superstar spokesperson.



Robert Dempsey

Robert Dempsey joined Shire in February 2014 as VP & Head of the Ophthalmics Business Unit. He has been instrumental in building a team of professionals with experience in commercial, medical and business development.

View Full Profile